Novetide Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Latest Deal Type
  • Joint Venture
  • Financing Rounds
  • 1

Novetide General Information

Description

Provider of peptide synthesis technology research and production processes. The company's peptide synthesis technology research and production processes is engaged in research and development, production and marketing of complex generic and innovative peptides, enabling pharmaceutical industry to avail tailor-made and cost effective management processes for their project.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • POB 10140
  • Haifa Bay 26111
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novetide Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novetide‘s full profile, request access.

Request a free trial

Novetide Executive Team (3)

Name Title Board Seat Contact Info
Avi Tovi Co-Founder, President & Chief Executive Officer
Dov Hirshenhouse Chief Financial Officer
Chaim Eidelman Ph.D Co-Founder & Vice President of Research & Development
To view Novetide’s complete executive team members history, request access »

Novetide Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novetide‘s full profile, request access.

Request a free trial